Adar1 Capital Management, LLC Savara Inc Transaction History
Adar1 Capital Management, LLC
- $652 Billion
- Q2 2025
A detailed history of Adar1 Capital Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 3,600,670 shares of SVRA stock, worth $9.29 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
3,600,670
Previous 1,360,291
164.7%
Holding current value
$9.29 Million
Previous $3.77 Billion
117.87%
% of portfolio
1.26%
Previous 0.7%
Shares
6 transactions
Others Institutions Holding SVRA
# of Institutions
129Shares Held
166MCall Options Held
38.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD24.5MShares$63.1 Million4.63% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$45.4 Million12.04% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$31.9 Million5.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$29.6 Million1.38% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$28.4 Million1.32% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $294M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.